Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ceramide metabolism pathway encompasses the synthesis, interconversion, and degradation of ceramides, bioactive sphingolipids that play critical roles in cell signaling, membrane structure, and disease processes. Key pathways include de novo synthesis, sphingomyelin hydrolysis, and the salvage pathway. Ceramides regulate apoptosis, cell growth arrest, differentiation, senescence, autophagy, inflammation, insulin resistance, and vascular function. Dysregulation of this pathway is implicated in metabolic syndrome and cardiovascular diseases.
The pathway itself is not a drug target, but specific enzymes within the pathway (e.g., SPT, CERS, ceramidases) are targeted by drugs to modulate ceramide levels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ceramide Metabolism Pathway.